Drugs / Acetyllevocarnitine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05319275 | Jul 2020 → Dec 2021 | diabetic polyneuropathy | Haisco Pharmaceutical Group Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acetyllevocarnitine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05319275 ↗ |